| 1 |
多糖注入的生物制造：组织工程和骨再生的3D生物打印进展 |
Polysaccharide-infused bio-fabrication: Advancements in 3D bioprinting for tissue engineering and bone regeneration |
2024 |
| 2 |
创建三维肝脏模型的工具箱 |
Toolbox for creating three-dimensional liver models |
2024 |
| 3 |
(3D) 生物打印：制药领域的下一维度 |
(3D) Bioprinting-Next Dimension of the Pharmaceutical Sector |
2024 |
| 4 |
微流控人类生理模拟肝脏模型作为药物诱导肝损伤的筛选平台 |
Microfluidic human physiomimetic liver model as a screening platform for drug induced liver injury |
2024 |
| 5 |
山葵过氧化物酶催化交联的甜菜果胶的3D生物打印 |
3D Bioprinting of Sugar Beet Pectin through Horseradish Peroxidase-Catalyzed Cross-Linking |
2024 |
| 6 |
解锁仿生生物墨水的潜力：哺乳动物组织生物打印的集体突破 |
Unlocking the potential of bio-inspired bioinks: A collective breakthrough in mammalian tissue bioprinting |
2024 |
| 7 |
3D打印脂质中相用于慢性肝病治疗 |
3D‐Printed Lipid Mesophases for the Treatment of Chronic Liver Disease |
2024 |
| 8 |
打印治疗方案：肝癌治疗中局部药物递送的定制解决方案 |
Printing a cure: A tailored solution for localized drug delivery in liver cancer treatment |
2024 |
| 9 |
仿生生物墨水用于制造化学机械相关的独立疾病模型 |
Bioinspired Bioinks for the Fabrication of Chemomechanically Relevant Standalone Disease Models of Hepatic Steatosis |
2024 |
| 10 |
无异种成分的3D生物打印肝模型用于肝毒性评估 |
Xeno-Free 3D Bioprinted Liver Model for Hepatotoxicity Assessment |
2024 |
| 11 |
含有多孔聚合物微粒的复合生物打印水凝胶为3D细胞培养提供可定制的机械性能 |
Composite Bioprinted Hydrogels Containing Porous Polymer Microparticles Provide Tailorable Mechanical Properties for 3D Cell Culture |
2024 |
| 12 |
设计和开发肝脏冻干基质粉末作为3D打印混合水凝胶的仿生组分 |
Design and development of a hepatic lyo-dECM powder as a biomimetic component for 3D-printable hybrid hydrogels |
2023 |
| 13 |
结合三种器官等效物的微生理系统和转录组学评估化妆品成分的毒性终点 |
Combining a microphysiological system of three organ equivalents and transcriptomics to assess toxicological endpoints for cosmetic ingredients |
2023 |
| 14 |
内部交联的海藻酸钠基生物墨水用于体外肝组织模型的制造 |
Internally crosslinked alginate-based bioinks for the fabrication of in vitro hepatic tissue models |
2023 |
| 15 |
从想法到现实：3D生物打印在再生医学和组织工程中的标志性历史 |
Out of Box Thinking to Tangible Science: A Benchmark History of 3D Bio-Printing in Regenerative Medicine and Tissues Engineering |
2023 |
| 16 |
3D生物打印用于下一代个性化医疗 |
3D Bioprinting for Next-Generation Personalized Medicine |
2023 |
| 17 |
PVA/壳聚糖交联3D支架的制备与表征用于肝组织工程 |
Preparation and characterization of PVA/Chitosan cross-linked 3D scaffolds for liver tissue engineering |
2023 |
| 18 |
Hep3Gel：一种适应不同培养系统的变形基质三维肝脏模型 |
Hep3Gel: A Shape-Shifting Extracellular Matrix-Based Three-Dimensional Liver Model Adaptable to Different Culture Systems |
2022 |
| 19 |
使用响应性生物材料打印智能构建物：精准医学的未来方向 |
Three-dimensional printing of smart constructs using stimuli-responsive biomaterials: A future direction of precision medicine |
2023 |
| 20 |
观点章节：设计和表征具有仿生3D微结构的天然和合成软聚合材料 |
Perspective Chapter: Design and Characterization of Natural and Synthetic Soft Polymeric Materials with Biomimetic 3D Microarchitecture for Tissue Engineering and Medical Applications |
2022 |
| 21 |
三维生物打印器官：现代成就 |
Three-dimensional bioprinting of organs. Modern achievements |
2022 |
| 22 |
生物打印多材料脱细胞肝基质水凝胶 |
3D Bioprinting of Multi-Material Decellularized Liver Matrix Hydrogel at Physiological Temperatures |
2022 |
| 23 |
高分辨率的黄原胶/纳米纤维素生物墨水的3D打印 |
High-resolution 3D printing of xanthan gum/nanocellulose bio-inks |
2022 |
| 24 |
使用肝实质和非实质细胞的3D生物打印体外仿生肝小叶微结构 |
Mimicking Native Liver Lobule Microarchitecture In Vitro with Parenchymal and Non-parenchymal Cells Using 3D Bioprinting for Drug Toxicity and Drug Screening Applications |
2022 |
| 25 |
纤维素纳米纤维增强榅桲种子粘液生物墨水的3D打印及其性质 |
3D printing and properties of cellulose nanofibrils-reinforced quince seed mucilage bio-inks |
2021 |
| 26 |
纳米纤维聚合物水凝胶的仿生生物墨水用于3D生物打印 |
Biomimetic bioinks of nanofibrillar polymeric hydrogels for 3D bioprinting |
2021 |
| 27 |
生物塑料作为3D和4D生物打印的人体组织工程结构的挑战 |
Challenges of Bioplastics as Bioinks for 3D and 4D Bioprinting of Human Tissue-Engineered Structures |
2021 |
| 28 |
建立与体内生理状态相似的3D体外肝脏模型 |
Establishing a 3D In Vitro Hepatic Model Mimicking Physiologically Relevant to In Vivo State |
2021 |
| 29 |
多组织单细胞分析解构小鼠自然杀伤细胞和I型先天淋巴细胞在组织和循环中的复杂程序 |
Multi-tissue single-cell analysis deconstructs the complex programs of mouse natural killer and type 1 innate lymphoid cells in tissues and circulation |
2021 |
| 30 |
3D生物打印的组织和器官的概述——综述 |
Overview of 3D Bioprinting of tissues and organs–A Review |
2021 |
| 31 |
光引发材料在组织生物打印中的应用 |
Guiding Lights: Tissue Bioprinting Using Photoactivated Materials |
2020 |
| 32 |
基于藻酸盐的三维生物墨水在生物医学应用中的最新趋势 |
Recent Trends in Three-Dimensional Bioinks Based on Alginate for Biomedical Applications |
2020 |
| 33 |
组织工程中的生物打印技术 |
Bioprinting Technologies in Tissue Engineering |
2020 |
| 34 |
基于胶原蛋白的药物诱导肝损伤模型 |
Collagen models of drug-induced liver injury |
2020 |
| 35 |
三维肝脏模型：现状及其在肝毒性评估中的应用 |
Three-dimensional liver models: state of the art and their application for hepatotoxicity evaluation |
2020 |
| 36 |
病人来源的结直肠癌转移支架作为肝转移微环境的类器官3D模型 |
Patient-Derived Scaffolds of Colorectal Cancer Metastases as an Organotypic 3D Model of the Liver Metastatic Microenvironment |
2020 |
| 37 |
人诱导多能干细胞来源的肝脏类球体的3D生物打印在体外维持肝功能和活力 |
3D bioprinting of liver spheroids derived from human induced pluripotent stem cells sustain liver function and viability in vitro |
2019 |
| 38 |
3D生物打印共培养作为肝组织模型的研究 |
Investigation of 3D Bioprinted Cocultures as Liver Tissue Models |
2019 |
| 39 |
通过挤出生物打印生成含有人类细胞外基质的3D肝脏模型用于感染和转导研究 |
Generation of a 3D Liver Model Comprising Human Extracellular Matrix in an Alginate/Gelatin-Based Bioink by Extrusion Bioprinting for Infection and Transduction Studies |
2018 |
| 40 |
由干细胞衍生的组织用于人类再生医学的三维生物打印 |
Three-dimensional bioprinting of stem-cell derived tissues for human regenerative medicine |
2018 |
| 41 |
使用人体肝脏细胞外基质作为组织特异性生物墨水的3D生物打印 |
3D bio-printing of human hepatic tissue using human liver extracellular matrix as tissue-specific bioink |
2018 |
| 42 |
用于制造骨支架的直接写入打印系统的建模与控制 |
Modeling and control of an easy-to-use direct write printing system for fabrication of bone scaffolds |
2017 |
| 43 |
用于移植的器官的3D生物打印 |
3D Bioprinting of Organs for Transplantation |
2024 |
| 44 |
生物打印肝组织用于药物诱导肝损伤测试的项目大纲 |
Project Outline: Bioprinted Liver Tissue for Drug Induced Liver Injury Testing |
2023 |
| 45 |
iPSC技术在软骨发育不良疾病模型中的应用 |
Application of iPSC technology to disease modeling for chondrodysplasia |
2020 |
